High-Value Niche iFyber operates as a specialized CRO with strengths in biocompatibility, antimicrobial testing, virology, wound care, biofilm, regenerative medicine, and regulatory-oriented studies (510(k)). This positions it well to pursue pharma, medical device, and cosmetic clients requiring complex pre-clinical and regulatory support.

Expansion Signals Recent leadership hires and the launch of advanced LC-MS services indicate active capacity building and capability expansion. This creates opportunities to upsell broader analytical offerings to existing clients and attract higher-tier projects that need integrated testing suites.

Award-Driven Validation Collaboration with Merakris Therapeutics leading to SAWC Best Laboratory Research Award enhances credibility. Use the award momentum to approach wound care and regenerative medicine firms seeking proven preclinical data and validated testing partners.

High-Throughput Biofilm Development of a high-throughput, surface-based dental biofilm assay demonstrates capability in material-level biocompatibility and microbial testing. This can be pitched to dental material manufacturers and biomaterials developers needing fast, predictive surface assays.

Strategic Partnerships Active involvement in industry events (Kilmer Conference) and collaboration with clinical-stage companies signals readiness for joint studies and data generation. Suggest outreach to potential collaborators in regenerative medicine, wound care, and anti-microbial spaces seeking co-development and evidence generation.